The authors report a case where a quantitative assessment of the apparent diffusion coefficient (ADC) of liver metastasis in a patient undergoing chemotherapy has shown to be an effective early marker for predicting therapeutic response, anticipating changes in tumor size. A lesion with lower initial ADC value and early increase in such value in the course of the treatment tends to present a better therapeutic response
Assessment of the effectiveness of cancer therapy traditionally relies on comparison of tumor images...
Validated biomarkers for treatment response in patients suffering from brain metastases are needed i...
In recent years, the use of diffusion weighted MRI (DW-MRI) has increased for the diagnosis of focal...
Purpose This study assessed the capability of magnetic resonance (MR) diffusion-weighted imaging (Dw...
Purpose: To evaluate the ability of the apparent diffusion coefficient (ADC) to help predict respons...
An imaging biomarker that would provide for an early quantitative metric of clinical treatment respo...
AbstractA goal of oncology is the individualization of patient care to optimize therapeutic response...
A goal of oncology is the individualization of patient care to optimize therapeutic responses and mi...
Background: Tumour apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance i...
OBJECTIVES: Before diffusion-weighted imaging (DWI) can be implemented in standard clinical practice...
Purpose. To determine whether change of apparent diffusion coefficient (ADC) value could predict ear...
Predicting outcomes in patients with hepatocellular carcinoma (HCC) who undergo locoregional therapi...
Breast cancer is the most common non-skin cancer in women and the second leading cause of cancer dea...
Background: The pathological response to preoperative chemotherapy of colorectal liver metastases (C...
The efficiency of an oncological treatment regimen is often assessed by morphological criteria such ...
Assessment of the effectiveness of cancer therapy traditionally relies on comparison of tumor images...
Validated biomarkers for treatment response in patients suffering from brain metastases are needed i...
In recent years, the use of diffusion weighted MRI (DW-MRI) has increased for the diagnosis of focal...
Purpose This study assessed the capability of magnetic resonance (MR) diffusion-weighted imaging (Dw...
Purpose: To evaluate the ability of the apparent diffusion coefficient (ADC) to help predict respons...
An imaging biomarker that would provide for an early quantitative metric of clinical treatment respo...
AbstractA goal of oncology is the individualization of patient care to optimize therapeutic response...
A goal of oncology is the individualization of patient care to optimize therapeutic responses and mi...
Background: Tumour apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance i...
OBJECTIVES: Before diffusion-weighted imaging (DWI) can be implemented in standard clinical practice...
Purpose. To determine whether change of apparent diffusion coefficient (ADC) value could predict ear...
Predicting outcomes in patients with hepatocellular carcinoma (HCC) who undergo locoregional therapi...
Breast cancer is the most common non-skin cancer in women and the second leading cause of cancer dea...
Background: The pathological response to preoperative chemotherapy of colorectal liver metastases (C...
The efficiency of an oncological treatment regimen is often assessed by morphological criteria such ...
Assessment of the effectiveness of cancer therapy traditionally relies on comparison of tumor images...
Validated biomarkers for treatment response in patients suffering from brain metastases are needed i...
In recent years, the use of diffusion weighted MRI (DW-MRI) has increased for the diagnosis of focal...